Avantor, Inc. (NYSE:AVTR) Receives $11.39 Consensus Target Price from Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have received an average recommendation of “Hold” from the fifteen analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $10.8214.

Several analysts have weighed in on AVTR shares. Wells Fargo & Company cut their target price on Avantor from $16.00 to $14.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Robert W. Baird set a $11.00 price target on Avantor in a research report on Thursday, February 12th. Jefferies Financial Group reiterated an “underperform” rating and set a $8.00 price target on shares of Avantor in a research report on Thursday, February 12th. TD Cowen reiterated a “hold” rating on shares of Avantor in a research report on Thursday, February 12th. Finally, Evercore set a $10.00 price target on Avantor in a research report on Wednesday, February 11th.

Insider Activity

In other news, Director Simon Dingemans purchased 25,000 shares of the stock in a transaction dated Friday, May 1st. The shares were bought at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the transaction, the director owned 25,000 shares in the company, valued at $203,500. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Sanjeev K. Mehra purchased 125,000 shares of the stock in a transaction dated Tuesday, March 10th. The shares were purchased at an average price of $8.01 per share, for a total transaction of $1,001,250.00. Following the completion of the transaction, the director owned 475,000 shares in the company, valued at $3,804,750. This trade represents a 35.71% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have bought 210,000 shares of company stock worth $1,745,950. 0.28% of the stock is owned by company insiders.

Institutional Investors Weigh In On Avantor

Institutional investors and hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its position in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the period. Strategic Wealth Investment Group LLC purchased a new position in shares of Avantor during the second quarter valued at $32,000. Private Trust Co. NA grew its stake in Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares in the last quarter. Osaic Holdings Inc. grew its stake in Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares in the last quarter. Finally, Los Angeles Capital Management LLC purchased a new position in Avantor in the fourth quarter valued at about $32,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Up 0.8%

Shares of Avantor stock opened at $7.93 on Friday. The business’s fifty day moving average price is $8.01 and its two-hundred day moving average price is $10.06. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.17. The company has a market capitalization of $5.41 billion, a P/E ratio of -9.79, a PEG ratio of 4.59 and a beta of 0.94. Avantor has a 1-year low of $7.26 and a 1-year high of $15.93.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, April 29th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.01. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The firm’s revenue for the quarter was up .0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.23 EPS. As a group, research analysts forecast that Avantor will post 0.79 EPS for the current year.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.